Life Science in Germany

JLL and KGAL examine the market for office and laboratory buildings – users have to dig deepest into their pockets in Berlin, while the most space is let in Munich

June 27, 2022

Investments in life science real estate have so far played a subordinate role at best among institutional investors – at least in Germany. This is likely to change in the coming years. Driven by the success of companies such as Biontech, research and laboratory facilities as well as associated office buildings are increasingly becoming the focus of national and international investors. As a result, rents and capital values are expected to rise, because the sector is focusing on high-quality space and is also prepared to pay the necessary rents for it. This is the conclusion reached by JLL and KGAL in their joint study "Life Science in Germany".

Table of Contents:

  • The importance of the life science segment in Germany
  • Location and site requirements of users
  • Life science real estate - characterisation, demarcation and user requirements
  • Lease characteristics in the life science segment
  • Life science rental market and rents in the most important clusters
  • Investment market and yields of life science properties

There was an error submitting the form. Please try again. 



Jones Lang LaSalle (JLL), together with its subsidiaries and affiliates, is a leading global provider of real estate and investment management services. We take our responsibility to protect the personal information provided to us seriously.

Generally the personal information we collect from you are for the purposes of dealing with your enquiry.

We endeavor to keep your personal information secure with appropriate level of security and keep for as long as we need it for legitimate business or legal reasons. We will then delete it safely and securely. For more information about how JLL processes your personal data, please view our privacy statement.